Patents
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
06/2004
06/10/2004WO2004048363A1 Imidazole derivative, process for producing the same, and use
06/10/2004WO2004048339A1 Isoquinoline compounds and medicinal use thereof
06/10/2004WO2004047769A2 Benzimidazoles and analogs thereof as antibacterials
06/10/2004WO2004047760A2 Novel chemical compounds
06/10/2004WO2004047725A2 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/10/2004US20040110945 Very Late Antigen (Vla-4); such as 4-((4S)-fluoro-1-(2-phenylamino-6-benzoxazolylacetyl)-(2S)-pyrrolidinylmethoxy)benzoic acid; for treatment of inflammatory diseases, autoimmune diseases, metastasis, bronchial asthma, rhinostenosis, and diabetes
06/10/2004US20040110944 4,7-Disubstituted indoles and methods of making
06/10/2004US20040110802 Antibacterial benzoic acid derivatives
06/10/2004US20040110798 A pyridyl-2yl-4-[1,2,3-triazole] derivatives therapeutic agent for treating cancer, glomerulonephritis, diabetic nephropathy, hepatic fibrosis, pulmonary fibrosis, hyperplasia, restenosis, skin disorders
06/10/2004US20040110797 Novel oxazole and thiazole compounds as transforming growth factor (TGF) inhibitors
06/10/2004US20040110785 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
06/10/2004US20040110782 Nitro and amino substituted heterocycles as topoisomerase I targeting agents
06/10/2004US20040110780 A cyclopenta[d]pyrimidine, or 5,6,7,8-tetrahydropyrido[4,3-d]pyrimidine derivatives; treating metabolic disorders, type II diabetes, controlling glucose levels
06/10/2004US20040110778 A 3,10-diaza-benzo[e]azulene, 3,8,10-triaza-benzo[e]azulene, or 1,3a,6-triaza-as-indacene derivatives, used to treat anxiety, depression, a sleep disorder, or Alzheimer's dementia.
06/10/2004US20040110764 Inhibit oncogene Ras; treating neurofibromin benign proliferative disorder; cancer (combination therapy); blindness, hepatitis infection, restenosis, polycystic kidney disease; imidazo[2,1-b]thiazole derivatives for example
06/10/2004US20040110763 Pyrazolopyridine compound and pharmaceutical use thereof
06/10/2004US20040110762 inhibitors of protein tyrosine kinase and are antiproliferative agents; 4-(4-phenoxyanilino)benzo[g]quinoline-3-carbonitrile for example; chemical intermediates, synthesis; treating polycystic kidney disease, colon polyps, cancer
06/10/2004US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct
06/10/2004US20040110753 Tyrosine derivatives
06/10/2004US20040110748 Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
06/10/2004US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
06/10/2004US20040110741 Substituted pyrazolyl compounds for the treatment of inflammation
06/10/2004US20040110126 Hcv polymerase inhibitor assay
06/10/2004US20040110031 emits a blue light with high emission luminance, high quantum efficiency and long half life and a display employing the organic element
06/10/2004US20040109890 Tablets quickly disintegrated in oral cavity
06/10/2004US20040107868 Colorless and not recognizable with the naked eye in visible rays, but is colored upon irradiation with UV(ultraviolet) rays, is highly soluble in a solvent particularly in a water-containing solvent, and stability of the solutions
06/10/2004US20040107518 Mass coloration of substrates, as colorants in electrophotographic toners and developers, in powders and powder coating materials, in ink-jet inks and in cosmetic compositions; colorfastnessfast; heat and chemical resistance; azo-methine dyes
06/10/2004CA2507256A1 Thiazolidine compounds in the treatment of anemic conditions
06/10/2004CA2507026A1 Imidazole derivatives, their production and use
06/10/2004CA2506656A1 Method of preparing inhibitors of phosphodiesterase-4
06/10/2004CA2506524A1 Pyrazoloquinolines with immunomodulating activity
06/10/2004CA2506310A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
06/10/2004CA2498566A1 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as hiv integrase inhibitors
06/09/2004EP1426375A2 Analgesic spiroindole derivatives
06/09/2004EP1426374A1 Naphthyridine derivative
06/09/2004EP1425281A1 Chemical compounds
06/09/2004EP1425280A2 Hetero-bicyclic crf antagonists
06/09/2004EP1425010A1 Substituted indoles and their use as integrin antagonists
06/09/2004EP1276742B1 Process for the preparation of pyrazolopyridine derivatives
06/09/2004EP1212323B1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
06/09/2004EP1171441B1 Morphinoid compounds
06/09/2004EP1100795B1 Disubstituted bicyclic heterocycles having, in particular, a thrombin inhibitive effect
06/09/2004EP1098897B1 Compounds, compositions, and methods for stimulating neuronal growth and elongation
06/09/2004CN1503797A Pyridopyrimidine or naphthyridine derivative
06/09/2004CN1503793A N-substituted nonabyl-heterocyclic nmda/nrzb antagonists
06/09/2004CN1503792A Phthalazinones derivatives useful as pde 4/7 inhibtors
06/09/2004CN1503787A Novel compounds
06/09/2004CN1503786A Large conductance calcium-activated k channel opener
06/09/2004CN1503784A 2-lminopyrrolidine derivatives
06/09/2004CN1503781A Process for the preparatino of 1,3-substituted indenes and aryl-fused azapolycyclic compounds
06/09/2004CN1503673A antiinflammation agents
06/09/2004CN1503672A 6-substituted pyrido-pyrimidines
06/09/2004CN1152879C Naphthyridine derivatives
06/09/2004CN1152877C Piperazine derivatives
06/09/2004CN1152874C Antipsychotic 4 (1 H-indolyl-1-YL)-1-substituted piperidine derivatives
06/09/2004CN1152867C Quinazoline derivatives as medicaments
06/09/2004CN1152866C Benzimidazoles, production thereof and use thereof medicaments
06/08/2004US6747151 Azo compounds for type I phototherapy
06/08/2004US6747150 For reducing rate of degradation of proteins in an animal; inhibiting hiv replication
06/08/2004US6747147 Oxo-azabicyclic compounds
06/08/2004US6747053 Heteroaryl nitriles
06/08/2004US6747040 Imidazonaphthyridines
06/08/2004US6747037 Treating ocular hypertension or glaucoma; reduced side effects
06/08/2004US6747034 CRF receptor antagonists and methods relating thereto
06/08/2004US6747032 Pyrimidin-4-one compounds
06/08/2004US6747028 1,2-substituted benzimidazoles having antiviral activity
06/08/2004US6746989 Substituted benzoylpyrazoles as herbicides
06/08/2004CA2307552C Substituted pyridine compounds as anti-inflammatory agents
06/03/2004WO2004046173A1 Scaffolds useful to the synthesis of compounds with biological activity
06/03/2004WO2004046146A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands
06/03/2004WO2004046145A1 Imidazo[1, 5a]pyridine derivatives and methods for treating aldosterone mediated diseases
06/03/2004WO2004046144A1 8-substituted imidazopyridines
06/03/2004WO2004046143A1 Substituted indolepyridinium as anti-infective compounds
06/03/2004WO2004046133A1 Amino-heterocycles as vr-1 antagonists for treating pain
06/03/2004WO2004046124A1 Benzoxazinone derivatives, preparation thereof and uses in the treatment of cns and other disorders
06/03/2004WO2004046120A2 Diaminotriazoles useful as inhibitors of protein kinases
06/03/2004WO2004046118A2 2-4-(di-phenyl-amino)-pyrimidine derivatives useful for treating hyper-proliferative disorders
06/03/2004WO2004046116A1 Novel process for the preparation of imidazolyl compounds
06/03/2004WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
06/03/2004WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring
06/03/2004WO2004024727A3 Synthesis of indolizines
06/03/2004WO2004022060A8 (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
06/03/2004WO2004018419A3 Benzimidazole quinolinones and uses thereof
06/03/2004WO2004014868A3 Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
06/03/2004WO2003092595A3 Tyrosine kinase inhibitors
06/03/2004WO2003086371A3 Use of ep4 receptor ligands in the treatment of il-6 involved diseases
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106833 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
06/03/2004US20040106791 dipyrido [1,4] diazepine derivatives; treating and preventing hiv
06/03/2004US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases
06/03/2004US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione
06/03/2004US20040106655 pyrrolo-2yl-carbonyl-amino compounds; dipeptidyl peptidase inhibitor
06/03/2004US20040106646 Visual function disorder improving agents
06/03/2004US20040106642 Polysubstituted imidazopyridines as gastric secretion inhibitors
06/03/2004US20040106641 e.g., N-(4-pyridylmethyl)-1-cyclopropylmethyl-7-azaindole-3-carboxylic acid amide
06/03/2004US20040106640 Aryl ether substituted imidazoquinolines
06/03/2004US20040106638 Sulfonamide and sulfamide substituted imidazoquinolines
06/03/2004US20040106635 Spiroisoquinoline compound, a method for preparing the same and an intermediate thereof
06/03/2004US20040106630 Bicyclic protein kinase inhibitors
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases